Avadel Pharmaceuticals Stock Options Expiring on 16th of January 2026

AVDL Stock  USD 10.00  0.15  1.48%   
Avadel Pharmaceuticals' latest option contracts expiring on 2026-01-16 are carrying combined implied volatility of 0.24 with a put-to-call open interest ratio of 27.78 over 16 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on 2026-01-16. The total put volume is at 130, with calls trading at the volume of 130. This yields a 0.39 put-to-call volume ratio.

Open Interest Against 2026-01-16 Option Contracts

The chart above shows Avadel Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Avadel Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Avadel Pharmaceuticals' option, there is no secondary market available for investors to trade.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avadel Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Avadel Pharmaceuticals In The Money Call Balance

When Avadel Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Avadel Pharmaceuticals PLC stock is said to be in the money. When it comes to buying Avadel Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Avadel Pharmaceuticals PLC are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Avadel Current Options Market Mood

Avadel Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Avadel Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Avadel Pharmaceuticals' options investors are not very successful. Avadel Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Avadel contract

Base on the Rule 16, the options market is currently suggesting that Avadel Pharmaceuticals PLC will have an average daily up or down price movement of about 0.015% per day over the life of the 2026-01-16 option contract. With Avadel Pharmaceuticals trading at USD 10.0, that is roughly USD 0.0015. If you think that the market is fully incorporating Avadel Pharmaceuticals' daily price movement you should consider buying Avadel Pharmaceuticals PLC options at the current volatility level of 0.24%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  

Avadel Pharmaceuticals Option Chain

When Avadel Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Avadel Pharmaceuticals PLC stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Avadel Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Avadel. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Avadel. It also shows strike prices and maturity days for a Avadel Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntExpirationCurrent SpreadLast Price
Call
AVDL Option Call 16-01-2026 502026-01-160.0 - 0.07.07In
Call
AVDL Option Call 16-01-2026 702026-01-160.0 - 0.03.8In
Call
AVDL Option Call 16-01-2026 1002026-01-160.0 - 0.02.7Out
Call
AVDL Option Call 16-01-2026 1202026-01-160.0 - 0.01.95Out
Call
AVDL Option Call 16-01-2026 1502026-01-160.0 - 0.01.55Out
Call
AVDL Option Call 16-01-2026 1702026-01-160.0 - 0.01.1Out
Call
AVDL Option Call 16-01-2026 2002026-01-160.0 - 0.00.7Out
Call
AVDL Option Call 16-01-2026 2202026-01-160.0 - 0.00.96Out
Call
AVDL Option Call 16-01-2026 25402026-01-160.0 - 0.71.6Out
Call
AVDL Option Call 16-01-2026 3002026-01-160.0 - 0.450.9Out
Call
AVDL Option Call 16-01-2026 3512026-01-160.1 - 0.30.4Out
 Put
AVDL Option Put 16-01-2026 5122026-01-160.0 - 0.80.4Out
 Put
AVDL Option Put 16-01-2026 702026-01-160.0 - 0.01.1Out
 Put
AVDL Option Put 16-01-2026 1002026-01-160.0 - 0.01.85Out
 Put
AVDL Option Put 16-01-2026 121162026-01-162.65 - 2.852.85In
 Put
AVDL Option Put 16-01-2026 1510112026-01-164.9 - 5.32.88In

Avadel Pharmaceuticals Market Cap Over Time

   Market Cap   
       Timeline  

Avadel Total Stockholder Equity

Total Stockholder Equity

47.09 Million

At this time, Avadel Pharmaceuticals' Total Stockholder Equity is quite stable compared to the past year.

Avadel Pharmaceuticals Corporate Management

Gregory DavisVP DevelopmentProfile
Richard KimChief OfficerProfile
Christian PharmDChief AffairsProfile
Steven SullivanVP OperationsProfile
Jason VaughnSenior OperationsProfile
Jennifer PharmDSenior AffairsProfile
When determining whether Avadel Pharmaceuticals is a strong investment it is important to analyze Avadel Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avadel Pharmaceuticals' future performance. For an informed investment choice regarding Avadel Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avadel Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.09)
Revenue Per Share
1.036
Quarterly Revenue Growth
26.743
Return On Assets
(0.34)
Return On Equity
(1.00)
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.